2026년 10월 25일 일요일

Medicare GLP-1 Bridge: Weight-Loss Drugs for a Flat $50 a Month


Since July 1, 2026, Medicare has run a demonstration program called the Medicare GLP-1 Bridge, and it does something Medicare had never done before: it covers certain weight-loss GLP-1 medications for a flat copay of $50 a month, regardless of your income or your dose. The program is open to people enrolled in Medicare Part D, it runs through December 31, 2027, and prior authorization is required. Here is who qualifies, which drugs are in, and the one catch you need to know before you count on the savings.

Which Drugs Does the GLP-1 Bridge Cover?

Only three products are in the Bridge, and the details matter. The program is administered centrally by the Centers for Medicare & Medicaid Services (CMS), not by your individual Part D plan, and the details are published at Medicare.gov/glp1bridge.

MedicationIn the Bridge?Notes
WegovyYesBoth the injection and the tablet form
ZepboundPartlyOnly the KwikPen; single-dose pens and vials are excluded
Foundayo (orforglipron)YesTablet form
Ozempic, Mounjaro, RybelsusNoThese are covered for diabetes through regular Part D rules, not the Bridge

The most common source of confusion is the brand name. Ozempic and Wegovy contain the same ingredient, but only Wegovy — the version approved for weight management — is in the Bridge. If you take a GLP-1 for diabetes, your coverage continues under your Part D plan as before.


Who Qualifies? The BMI Rules

Eligibility is based on body mass index (BMI) plus, at lower BMI levels, a related health condition:

  • BMI of 35 or higher: You qualify on BMI alone.
  • BMI of 30 or higher: You qualify if you also have heart failure, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or worse.
  • BMI of 27 or higher: You qualify if you also have prediabetes or a history of heart attack, stroke, or peripheral artery disease.

Your prescriber documents this as part of the prior authorization. If your BMI is below 27, the Bridge does not apply, and weight-loss medication coverage would depend on your plan's regular rules — which, for most Part D plans, means it is not covered at all.

What Is the Catch? The $50 Does Not Count Toward Your Cap

The $50 copay is genuinely flat — it does not change with your income or your dose. But there is a trade-off built into the design: Bridge payments do not count toward your Part D deductible or your annual out-of-pocket cap.

That matters if you take other expensive prescriptions. Money you spend through the Bridge does not move you closer to the point where your other covered drugs become free for the rest of the year. Run both numbers — your expected Bridge copays and your other drug spending — before assuming the program is the cheapest route for your whole medication list.

How Do You Enroll?

There is no separate application form for you to file. Talk with the clinician who manages your weight care, confirm that your BMI and health history fit one of the groups above, and ask them to submit the prior authorization with the drug — Wegovy, the Zepbound KwikPen, or Foundayo — that fits your situation. Because CMS runs the Bridge centrally, the process is the same whatever Part D plan you have.


Frequently Asked Questions

Does the $50 copay depend on my income?
No. According to CMS, the Bridge copay is a flat $50 a month, the same for everyone in the program, whatever the dose.

Is Ozempic covered by the Bridge?
No. Ozempic, Mounjaro, and Rybelsus are outside the Bridge. They remain Part D drugs for diabetes under your plan's normal rules.

When does the Bridge end?
December 31, 2027. It is an 18-month demonstration, so coverage under these terms is not permanent. If you start a medication through the Bridge, ask early what your options will be when the program ends.

Can I use the Bridge if I have a Medicare Advantage plan?
The Bridge is for people with Part D drug coverage, which includes Medicare Advantage plans that include drug coverage. The prior authorization is handled through the CMS process, not your plan's own drug rules.

Key Takeaway

The Medicare GLP-1 Bridge offers eligible Part D enrollees Wegovy, the Zepbound KwikPen, or Foundayo for a flat $50 a month from July 1, 2026 through December 31, 2027. Qualification turns on BMI: 35 or higher on its own, 30 or higher with heart failure, uncontrolled hypertension, or stage 3a kidney disease, and 27 or higher with prediabetes or a history of heart attack, stroke, or peripheral artery disease. Remember the trade-off — Bridge copays do not count toward your Part D deductible or out-of-pocket cap — and discuss the full picture with your doctor and pharmacist before you start.

This article was written with the help of generative AI.

For general information only, not medical advice.

Consult a qualified professional for your situation.

0 comments

댓글 쓰기

6271248431392384383